7.93
-0.3902(-4.69%)
Currency In USD
| Previous Close | 8.32 |
| Open | 9.01 |
| Day High | 9.2 |
| Day Low | 7.93 |
| 52-Week High | 17.4 |
| 52-Week Low | 5 |
| Volume | 2,913 |
| Average Volume | 18,205 |
| Market Cap | 10M |
| PE | -0.37 |
| EPS | -21.29 |
| Moving Average 50 Days | 8.1 |
| Moving Average 200 Days | 8.47 |
| Change | -0.39 |
If you invested $1000 in Sensei Biotherapeutics, Inc. (SNSE) since IPO date, it would be worth $20.98 as of September 08, 2025 at a share price of $7.93. Whereas If you bought $1000 worth of Sensei Biotherapeutics, Inc. (SNSE) shares 3 years ago, it would be worth $204.38 as of September 08, 2025 at a share price of $7.93.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 03, 2025 12:00 PM GMT
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John C
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
GlobeNewswire Inc.
Jul 30, 2025 11:30 AM GMT
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clini
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
GlobeNewswire Inc.
Jun 13, 2025 11:30 AM GMT
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will